(Q35212546)

7 August 2017

1 reference

title

Role of endothelial dysfunction in insulin resistance (English)

1 reference

7 August 2017

0 references

1 reference

1 reference

Willa A Hsueh

1

1 reference

PubMed ID

12957322

7 August 2017

Manuel J Quiñones

series ordinal

2

1 reference

PubMed ID

12957322

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

American Journal of Cardiology

7 August 2017

1 reference

7 August 2017

92

1 reference

7 August 2017

4A

1 reference

7 August 2017

10J-17J

1 reference

Endothelial dysfunction: does it matter? Is it reversible?

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Angiotensin II and the pathophysiology of cardiovascular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Effect of a single high-fat meal on endothelial function in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Nitric oxide release accounts for insulin's vascular effects in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Signaling pathways in insulin action: molecular targets of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

The cardiovascular dysmetabolic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Endothelial dysfunction in men with small LDL particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Antioxidant vitamin C improves endothelial dysfunction in chronic smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Atherosclerosis and the two faces of endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Vitamin E supplementation and cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Roles of PPARs in health and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Invited review: Pharmacogenetics of estrogen replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Vitamin C increases nitric oxide availability in coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

PPAR gamma and the treatment of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

PPARgamma and atherosclerosis: effects on cell growth and movement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Troglitazone improves endothelial dysfunction in patients with insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900611-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(03)00611-8

1 reference

7 August 2017

1 reference

PubMed ID

12957322